Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m

Name: Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m
Published: 2006
License: Public Domain

GlaxoSmithKline · 2006

ClinicalTrials.gov · Datasets · License: Public Domain · 2006

Open Source ↗

diphtheria hepatitisb pertussis

whole cell pertussis, haemophilus influenzae type b, hepatitis b, diphtheria, tetanus, diphtheria-tetanus-pertussis-hepatitis b-haemophilus influenzae type b-neisseria meningitidis vaccin, prophylaxis diphtheria, hib & meningococcal serogroup a & c disease, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m

Related documents